BioCentury
ARTICLE | Company News

Sinobioway provides update on its bid to acquire Sinovac

August 11, 2017 8:28 PM UTC

A consortium led by Shandong Sinobioway Biomedicine Co. Ltd. (SZSE:002581) said it submitted all required documents to Sinovac Biotech Ltd. (NASDAQ:SVA) to prove it has sufficient funds to finance an $8 per share bid to acquire Sinovac. The consortium offered the bid in late June, shortly after Sinovac said it accepted a $7 per share bid from an investor syndicate led by Sinovac CEO Weidong Yin and SAIF Partners. The syndicate intends to take Sinovac private (see BioCentury, July 10)...